Literature DB >> 3409810

[Lysis treatment of left ventricular thrombi. Acute and long-term results].

D G Mathey1, V Siglow, P Kremer, J Schofer, V Tilsner.   

Abstract

Intravenous thrombolysis with urokinase (60,000 U/h) was undertaken in 15 patients with large thrombi in the left ventricle (demonstrated by echocardiography) after myocardial infarction. Complete lysis was achieved in ten, partial in four. None had post-thrombolysis signs of arterial emboli, two patients developed haematuria and one had partial separation of the thrombus which required operative removal. Four patients who had a mean ejection fraction of 37 +/- 12% had died a sudden cardiac death within six months of the thrombolysis. Nine patients survived for up to four years without recurrence of thrombi: seven of them had been treated with aspirin (acetylsalicylic acid), two with coumarin derivatives. Two patients could not be followed-up. These preliminary results suggest that large left-ventricular thrombi can be successfully lysed by intravenous thrombolysis without significant complications, probably without recurrent thrombi.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3409810     DOI: 10.1055/s-2008-1067804

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  3 in total

1.  Fibrinolytic treatment in left ventricular mobile thrombi with low ejection fraction: results and follow-up of seven cases.

Authors:  Ibrahim Sari; Vedat Davutoğlu; Serdar Soydinc; Murat Sucu; Orhan Ozer
Journal:  J Thromb Thrombolysis       Date:  2007-05-11       Impact factor: 2.300

2.  Complete lysis of left ventricular giant thrombus with fibrinolytic therapy in clopidogrel resistant patient.

Authors:  Vedat Davutoglu; Serdar Soydinc; Yusuf Sezen
Journal:  J Thromb Thrombolysis       Date:  2003-02       Impact factor: 2.300

Review 3.  Thrombolysis in thromboembolic diseases.

Authors:  D C Gulba; R Dechend
Journal:  Ann Hematol       Date:  1994-10       Impact factor: 3.673

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.